We are live on ! Find out more
CLVS

Clovis Oncology, Inc.
CLVS

Delisted

CLVS was delisted on the 20th of December, 2022.

Back to rankings

109 hedge funds and large institutions have $1.43B invested in Clovis Oncology, Inc. in 2013 Q2 according to their latest regulatory filings, with 109 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
109
Holders Change
+109
Holders Change %
–
% of All Funds
3.56%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.16%
New
109
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$297M +$200M +4,439,762 New
NMC
2
NEA Management Company
Maryland
$153M +$103M +2,279,781 New
PHS
3
PFM Health Sciences
California
$136M +$91.1M +2,025,456 New
CPCM
4
Clifton Park Capital Management
Delaware
$62M +$41.6M +925,000 New
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$59.3M +$39.8M +885,443 New
Vanguard Group
6
Vanguard Group
Pennsylvania
$49.8M +$33.5M +743,888 New
SCA
7
SAC Capital Advisors
Connecticut
$46.5M +$31.2M +693,729 New
QF
8
QVT Financial
New York
$41.4M +$27.8M +617,678 New
BFA
9
BlackRock Fund Advisors
California
$37.3M +$25M +556,957 New
BBA
10
Baker Bros. Advisors
New York
$35.2M +$23.6M +525,113 New
RG
11
Redmile Group
California
$31.8M +$21.4M +475,377 New
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$27M +$18.1M +403,201 New
Millennium Management
13
Millennium Management
New York
$25.8M +$17.3M +385,379 New
State Street
14
State Street
Massachusetts
$24.5M +$16.4M +365,633 New
AllianceBernstein
15
AllianceBernstein
Tennessee
$23.3M +$15.7M +348,402 New
Lord, Abbett & Co
16
Lord, Abbett & Co
New Jersey
$22.1M +$14.8M +329,441 New
TCM
17
TimesSquare Capital Management
New York
$21.6M +$14.5M +322,250 New
Franklin Resources
18
Franklin Resources
California
$21.4M +$14.3M +318,900 New
WSA
19
Wall Street Associates
California
$20.8M +$14M +310,340 New
DM
20
Deerfield Management
New York
$20.5M +$13.8M +306,018 New
BIT
21
BlackRock Institutional Trust
California
$17.8M +$12M +266,134 New
California Public Employees Retirement System
22
California Public Employees Retirement System
California
$15.7M +$10.5M +233,943 New
Northern Trust
23
Northern Trust
Illinois
$14.4M +$9.64M +214,453 New
SAM
24
Sectoral Asset Management
Quebec, Canada
$14.2M +$9.56M +212,700 New
VAM
25
Visium Asset Management
New York
$14.1M +$9.49M +210,970 New
1
2 3 4 5

CLVS Hedge Fund Activity: Q2 2013 in Review

109 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Clovis Oncology, Inc. (CLVS) for Q2 2013, worth a combined $1.43B.

Buyers outnumbered sellers: 109 funds opened new CLVS positions and 0 closed out — a net gain of 109 holders — while 0 added to existing stakes and 0 trimmed.

  • 109 institutional investors held Clovis Oncology, Inc. (CLVS) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.43B of Clovis Oncology, Inc. stock for Q2 2013.
  • 109 funds opened new Clovis Oncology, Inc. positions in Q2 2013 and 0 closed out, a net change of +109 holders.

Based on aggregated 13F filings for Q2 2013.